15 Mar 2013
ERJ staff report (LMH)
Pittsfield, Massachusetts – Dow Corning presented a new silicone technology for the company’s high consistency rubber (HCR) product line at the recent MD&M West trade fair in Anaheim, California.
The one-part QP1 silicone elastomer are supplied uncatalysed to offer medical device OEMs and fabricators processing flexibility, enabling them to choose the most suitable formulation for each application, Dow Corning said in a statement. The company said the materials provide high strength and can be platinum catalysed using masterbatches, or cured using a peroxide-initiate system.
“Our new QP1 silicone elastomer products are designed to give customers more options to meet changing requirements and market trends for medical devices, while also addressing the healthcare industry’s need for greater manufacturing freedom,” commented James Stevenson, global market director, Dow Corning Healthcare.
The silicone elastomers are US Food & Drug Administration food contact compliant. There are supplied in Short A hardnesses of 30, 50, 60 and 70, and are formulated with the use of solvents, phthalates or latex additives.
This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.
News Release from Dow Corning
Subscribe for unlimited access. A subscription to European Rubber Journal includes:
Already a subscriber? Log in here
